학술논문

Valemetostat for Relapsed or Refractory B-Cell Lymphomas: Primary Results from a Phase 1 Trial
Document Type
Journal
Source
BLOOD; NOV 2 2023, 142 4p. Supplement: 1
Subject
Language
English
ISSN
15280020